Evaluation of the Vaccine Effectiveness 11 years after 4vHPV Vaccination Among Young Women in Mongolia

This study evaluated the long-term effectiveness of the three-dose 4vHPV vaccine eleven years after a 2012 pilot program in Mongolia. It assessed women aged 24–28 for protection against HPV16/18 using self-collected vaginal samples and GenExpert testing. Results showed 88% effectiveness against vaccine-type HPV but no cross-protection against other high-risk types. Knowledge of HPV and cervical […]

Considerations for school-based HPV immunization: А Nationwide survey in Mongolia

This qualitative study explored school-based HPV immunization in Mongolia following the 2023 amendment making HPV vaccination mandatory. Focus groups with 13 teachers from four regions revealed declining parental confidence in vaccines, misinformation, and logistical barriers, particularly in rural areas. Teachers highlighted challenges such as vaccine storage, transportation, and the need for clearer roles of school […]

Parents’ and HCW attitudes towards HPV vaccine in Mongolia: A nationwide survey

This nationwide cross-sectional survey in Mongolia assessed parents’ and health workers’ attitudes toward HPV vaccination ahead of its mandatory introduction in 2024. Data from 3,057 parents and 416 health workers revealed 79% of parents and 50% of health workers hesitant to vaccinate due to concerns over safety, term effects, and side effects. Attitudes varied by […]

Country Snapshots – Mongolia

Mongolia is integrating HPV vaccination into its national immunization program under the Vision‑2050 development policy and amended immunization law (2023). A single-dose Gardasil schedule will target 11-year-olds, aiming to vaccinate 75% of 78,963 eligible children (~59,000) during the third quarter of 2024 via schools and family health centers. Preparations included national trainings for over 120 […]

>